H. Barlebo

1.6k total citations
22 papers, 1.2k citations indexed

About

H. Barlebo is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, H. Barlebo has authored 22 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in H. Barlebo's work include Bladder and Urothelial Cancer Treatments (7 papers), Urinary and Genital Oncology Studies (7 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). H. Barlebo is often cited by papers focused on Bladder and Urothelial Cancer Treatments (7 papers), Urinary and Genital Oncology Studies (7 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). H. Barlebo collaborates with scholars based in Denmark, Netherlands and Germany. H. Barlebo's co-authors include H Starklint, Hans Svanholm, S Olsen, H.J.G. Gundersen, J Fabricius, Jørgen Kvist Kristensen, H. H. Holm, Steen Walter, Hans Wolf and Sten Nørby Rasmussen and has published in prestigious journals such as Histopathology, Maturitas and Ultrasonics.

In The Last Decade

H. Barlebo

22 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Barlebo Denmark 13 540 274 240 218 195 22 1.2k
M.A. Batata United States 22 1.1k 2.0× 624 2.3× 237 1.0× 225 1.0× 81 0.4× 44 1.7k
Alfred B. Kurtz United States 29 798 1.5× 468 1.7× 119 0.5× 82 0.4× 383 2.0× 89 2.5k
B Gattegno France 23 650 1.2× 806 2.9× 222 0.9× 351 1.6× 92 0.5× 121 1.6k
Eduardo Orihuela United States 20 820 1.5× 820 3.0× 144 0.6× 295 1.4× 252 1.3× 71 1.7k
Beverly G. Coleman United States 24 1.3k 2.4× 846 3.1× 127 0.5× 376 1.7× 220 1.1× 75 2.8k
Hans Henrik Holm Denmark 16 301 0.6× 350 1.3× 91 0.4× 108 0.5× 93 0.5× 31 787
Marshall C. Mintz United States 18 353 0.7× 383 1.4× 60 0.3× 135 0.6× 155 0.8× 44 1.2k
B. Doré France 19 347 0.6× 864 3.2× 254 1.1× 331 1.5× 48 0.2× 112 1.3k
Zoran L. Barbaric United States 18 691 1.3× 592 2.2× 499 2.1× 255 1.2× 203 1.0× 65 1.4k
P H Arger United States 20 412 0.8× 399 1.5× 130 0.5× 105 0.5× 234 1.2× 33 1.1k

Countries citing papers authored by H. Barlebo

Since Specialization
Citations

This map shows the geographic impact of H. Barlebo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Barlebo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Barlebo more than expected).

Fields of papers citing papers by H. Barlebo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Barlebo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Barlebo. The network helps show where H. Barlebo may publish in the future.

Co-authorship network of co-authors of H. Barlebo

This figure shows the co-authorship network connecting the top 25 collaborators of H. Barlebo. A scholar is included among the top collaborators of H. Barlebo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Barlebo. H. Barlebo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sengeløv, Lisa, Hans von der Maase, Finn Lundbeck, et al.. (2002). Neoadjuvant Chemotherapy with Cisplatin and Methotrexate in Patients with Muscle-Invasive Bladder Tumours. Acta Oncologica. 41(5). 447–456. 55 indexed citations
2.
Barlebo, H., et al.. (1993). Intratubular germ cell neoplasia in an infantile testis with immature teratoma. Histopathology. 22(1). 69–72. 12 indexed citations
3.
Cardozo, L., Hans Rekers, A Tapp, et al.. (1993). Oestriol in the treatment of postmenopausal urgency: a multicentre study. Maturitas. 18(1). 47–53. 88 indexed citations
4.
Sell, A, Anders Jakobsen, B Nerstrøm, et al.. (1991). Treatment of advanced bladder cancer category T2 T3 and T4a. A randomized multicenter study of preoperative irradiation and cystectomy versus radical irradiation and early salvage cystectomy for residual tumor. DAVECA protocol 8201. Danish Vesical Cancer Group.. PubMed. 138. 193–201. 72 indexed citations
5.
Svanholm, Hans, H Starklint, H. Barlebo, & S Olsen. (1990). Histological evaluation of prostatic cancer (III): Reproducibility of assessment of tumour volume and its possible significance for prognosis. Apmis. 98(1-6). 237–243. 4 indexed citations
6.
Kjærgaard, Benedict, et al.. (1990). [Treatment with low-dose vaginal estradiol in post-menopausal women. A double-blind controlled trial].. PubMed. 152(10). 658–9. 15 indexed citations
7.
Svanholm, Hans, H Starklint, H. Barlebo, & S Olsen. (1990). Histological evaluation of prostatic cancer (II): Reproducibility of a histological grading system. Apmis. 98(1-6). 229–236. 7 indexed citations
8.
Svanholm, Hans, H Starklint, H.J.G. Gundersen, et al.. (1989). Reproducibility of histomorphologic diagnoses with special reference to the kappa statistic. Apmis. 97(7-12). 689–698. 406 indexed citations
9.
Svanholm, Hans, H Starklint, H. Barlebo, & S Olsen. (1989). Histological evaluation of prostatic cancer. Apmis. 97(7-12). 699–704. 10 indexed citations
10.
Barlebo, H., et al.. (1986). The Copenhagen bladder cancer project I.. PubMed. 33(3). 151–4. 6 indexed citations
11.
Barlebo, H., Munetomo Enjoji, G. D. CHISHOLM, et al.. (1986). Transitional cell carcinoma in situ.. PubMed. 221. 85–96. 7 indexed citations
12.
Jacobsen, Grete Krag, H. Barlebo, Jens Olsen, et al.. (1984). Testicular Germ Cell Tumours in Denmark 1976–1980 Pathology of 1058 Consecutive Cases. Acta Radiologica Oncology. 23(4). 239–247. 135 indexed citations
13.
Herz, F., H. Barlebo, & Leopold G. Koss. (1974). Modulation of alkaline phosphatase activity in cell cultures derived from human urinary bladder carcinoma.. PubMed. 34(8). 1943–6. 24 indexed citations
14.
Rasmussen, Søren N., H. H. Holm, Jørgen Kvist Kristensen, & H. Barlebo. (1972). Ultrasonically-guided Liver Biopsy. BMJ. 2(5812). 500–502. 73 indexed citations
15.
Kristensen, Jørgen Kvist, H. H. Holm, Sten Nørby Rasmussen, & H. Barlebo. (1972). Ultrasonically Guided Percutaneous Puncture of Renal Masses. Scandinavian Journal of Urology and Nephrology. 6(sup15). 49–56. 46 indexed citations
16.
Barlebo, H., et al.. (1972). Carcinoma in Situ of the Urinary Bladder Flat Intra-epithelial Neoplasia. Scandinavian Journal of Urology and Nephrology. 6(3). 213–223. 19 indexed citations
17.
Barlebo, H. & Bent L. Sørensen. (1972). Flat Epithelial Changes in the Urinary Bladder in Patients with Prostatic Hypertrophy. Scandinavian Journal of Urology and Nephrology. 6(sup15). 121–128. 4 indexed citations
18.
Sørensen, Bent L., et al.. (1969). Carcinoma of the Urinary Bladder: Clinical staging and histologic grading in relation to survival. Scandinavian Journal of Urology and Nephrology. 3(3). 189–192. 7 indexed citations
19.
Sørensen, Bent L., et al.. (1969). Ultraviolet Light Cystoscopy in Patients with Bladder Cancer: One Year's Experience. Scandinavian Journal of Urology and Nephrology. 3(3). 193–200. 4 indexed citations
20.
Barlebo, H., et al.. (1963). [LEIOMYOSARCOMA OF THE DUODENUM. A CASE WITH SEVERE PROTRACTED MELENA TREATED BY PANCREATICO-DUODENECTOMY].. PubMed. 125. 1278–81. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026